Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Asian Market Recap: Nikkei +0.07%, Hang Seng +0.69%, Shanghai Composite +0.87% as of 03:10 ET

Nov 25 ,2025

  • Synopsis:

    • Asia equities traded largely higher Tuesday although most ended away from their peaks. Greater China held on to see gains in all three major benchmarks; Japan's boards pared opening gains as the Topix fell and the Nikkei flatlined. Modest gains for South Korea and Australia, Taiwan leading the region with a surge in its chip stocks. Singapore lower, other Southeast Asia benchmarks mostly higher. India a few points ahead. US futures a little lower, Europe opened slightly higher. US dollar DXY index continues to hover near 100, won weakened to eight-month low. Treasury and JGB yields higher across tenors. Crude oil remains under pressure on Ukraine War hopes. Gold and silver surging as Fed rate cut decision nears. Base metals led higher by iron ore back at a three-week high. Cryptocurrencies mixed.

    • Asia equities continued Monday's momentum to end largely higher Tuesday with a surge on Wall Street again providing support. However, with futures indicating a slightly softer open in the US, most major benchmarks closed away from their highs. Fed Fund Futures now showing an 81% chance of a Fed rate cut in December, up from around 70% yesterday following dovish comments from Fed Reserve governor Waller. Regional technology names also supported by Alphabet's rise after hours on reports it is in talks with Meta to supply AI chips in its data centers, leading to outperformance in Taiwan-based suppliers especially.

    • In regional developments, China-US tensions eased further after a direct call between presidents Trump and Xi ended with Trump saying he had been invited to China for a state visit in April. Discussions said to include Taiwan however the Japan-China diplomatic row over PM Takaichi's comments on Taiwan showing few signs of easing. Few data points Tuesday to change sentiment although South Korea consumer morale came in at an eight-year high just as the BOK prepares to decide on rates Thursday, with almost all economists expecting no change. Thailand posted a higher than expected trade deficit ahead of the BoT's rate decision in December.

    • Lynas Rare Earths (LYC.AU) downgraded production from its Kalgoorlie processing plant due to clean energy unreliability. ISU Petasys (007660.KS) and MediaTek (2454.TT) stocks rose sharply on read across from reports Meta was set to spend billions of dollars on Alphabet's AI chips over Nvidia's. Sembcorp Industries (U96.SP) has revived plans to list its India unit in H2 2026 after its previous attempt was pulled in January. Woodside Energy (WDS.AU) has signed a cooperation agreement with Timor-Leste to study the maturity of a 5M tonne per annum LNG project.

  • Digest:

    • Trump-Xi dialogue maintains positive tone:

      • US President Trump posted on Truth Social that he concluded a "very good" phone call with Xi Jinping in a previously unannounced follow-up to their meeting in South Korea. Noted discussions included Ukraine/Russia, fentanyl, soybeans and other farm products. Lauded the deal on agriculture. Trump accepted an invitation to visit Beijing next April, while Xi will go on a state visit to the US later in the year. Positive tone was reciprocated by Xi's summary (Xinhua), noting the success of the Busan summit in recalibrating the direction of bilateral relations, which have since maintained a "steady and positive trajectory." Details were light though reiterated plans for Taiwan's re-integration to China. Bloomberg sources said US and China still negotiating key details of how Beijing will free up rare earth exports, aiming to agree on terms for "general licenses" that China pledged to offer for US-bound exports of rare earths and critical minerals by month's end. Tied in recent indications the Trump administration is mulling the sale of more advanced AI chips to Beijing, which was not discussed at the Trump-Xi meeting in Busan. Commerce Secretary Lutnick acknowledged Trump is hearing various views on the matter and will be Trump's call to make.

    • Japan earnings -- winners driven by AI, losers by US tariffs:

      • Nikkei added to earnings digests, ranking 2,300 listed companies that have reported H1 results by absolute year-ago net profit changes. Performance leaned positive with some 60% reporting larger profits and 40% with lower earnings. AI theme was the main bright spot, providing tailwinds for a number of sectors. In contrast, automakers lagged amid US tariff costs and yen strength. SoftBank (9984.JP) was the outlier with JPY1.92T ($12.2B) growth in net income dwarfing the rest. AI ripple effects boosted companies in the semiconductor supply chain as well as those involved in data center infrastructure. Hitachi (6501.JP) and Advantest (6857.JP) made the top ten, while Mitsubishi Electric (6503.JP) was another notable mention at 14th place. Banks were also among the top performers with Sumitomo Mitsui (8316.JP) at fourth and Mizuho (8411.JP) at seventh. Trading houses -- Marubeni (8002.JP), Itochu (8001.JP), Sumitomo Corp (8053.JP) -- made the top 25 as non-commodities segments drove earnings against the backdrop of weak raw materials markets. Among laggards, most of the auto majors were in the bottom 15. US tariffs also dragged marine transportation majors Nippon Yusen (9101.JP), Mitsui OSK (9104.JP), Kawasaki Kisen (9107.JP) into the bottom 10. However, article cited many bullish views that overall results were solid considering US tariff drags were not as bad as expected and companies are still proactively implementing price hikes.

    • StreetAccount Event Preview: RBNZ 26-Nov policy meeting

      • RBNZ expected to cut official cash rate (OCR) by 25 bp to 2.25% at its 26-Nov policy meeting. Some thought MPC will also debate case for a consecutive 50 bp cut with data on spending, services, housing and labor market remaining subdued and pointing to continued economic weakness. RBNZ seen downgrading GDP forecasts after Q2 GDP contraction was considerably larger than its prior forecasts. Central bank will look through CPI hitting 3% ceiling in Q3 with inflation seen moderating through 2026 amid a still-large negative output gap. OCR path will get usual outsized attention, including extent to which RBNZ lowers terminal rate estimate from current 2.55%. BofA predicts ~45 bp downward revision to new trough of 2.10% (similar to market pricing). That is expected to be accompanied by somewhat dovish forward guidance signaling openness to further easing but dependent on data. UBS anticipates November's will be final rate cut before a holding period with OCR in expansionary territory, New Zealand economic recovery expected to take hold in 2026 and two-way risks surrounding inflation outlook.

    • StreetAccount Event Preview: Bank of Korea policy meeting, 27 November

      • Bank of Korea widely expected to keep policy rate steady at 2.5% for fourth consecutive meeting Thursday as won remains weak near eight-month lows, and despite property price increases in Seoul moderating and US trade deal removing uncertainty layer. Bank expected to raise FY-25 growth forecasts from 0.9%, FY26 forecast from 1.6% to around 1.8% as 'K' shaped recovery continues amid tech strength, lag in other sectors. Meanwhile, housing transactions contracted since third stabilization measure introduced however household debt remains elevated. Accompanying statement will be watched carefully for any hint of hawkish turn. Inflation ticked higher in September and October, likely on won depreciation but expected to restart downward trajectory; Q3 GDP also higher than expected to give BOK room to hold. Yonhap noted around half of local economists in poll expect 25 bps cut within three months, half for no change.

    • Notable Gainers:

      • +4.3% 1810.HK (Xiaomi): chairman Lei Jun discloses purchase of 2.6M class B ordinary shares at an average HK$38.58/share

      • +1.8% 9531.JP (Tokyo Gas): report of intending to sell Ginza gCUBE in Tokyo for more than ¥30B

      • +1.3% 051910.KS (LG Chem): to divest 1.5M TL Chemical shares to JV partner Taekwang Industrial for KRW49.15B

      • +1.1% 4578.JP (Otsuka Holdings): submits NDA to US FDA for Centanafadine for treatment of ADHD

      • +0.7% 293.HK (Cathay Pacific Airways): reports October traffic +30.4% y/y

    • Notable Decliners:

      • -3.1% 035420.KS (NAVER): report of Naver Financial-Dunamu share swap ratio may be higher than expected at 1:3.3-3.4

      • -1.2% 5274.TT (ASPEED Technology): sees order visibility till 2Q26; revises up again Q4 revenue vs prior guidance NT$2.00-2.10B with increasing gross margin; optimistic about continued upward performance in 2026

      • -0.6% 120110.KS (Kolon Industries): to merge with Kolon ENP, effective 1-Apr

  • Data:

    • Economic:

      • No economic data today

    • Markets:

      • Nikkei: 33.64 or +0.07% to 48659.52

      • Hang Seng: 178.05 or +0.69% to 25894.55

      • Shanghai Composite: 33.26 or +0.87% to 3870.02

      • Shenzhen Composite: 33.97 or +1.42% to 2424.95

      • ASX200: 11.90 or +0.14% to 8537.00

      • KOSPI: 11.72 or +0.30% to 3857.78

      • SENSEX: 108.84 or +0.13% to 85009.55

    • Currencies:

      • $-¥: (0.28) or (0.18%) to 156.6340

      • $-KRW: (4.76) or (0.32%) to 1469.9100

      • A$-$: (0.00) or (0.14%) to 0.6454

      • $-INR: +0.09 or +0.10% to 89.2365

      • $-CNY: (0.01) or (0.13%) to 7.0939

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE